Published on in Vol 9, No 6 (2020): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17223, first published .
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study

Arthi Chinna Meyyappan 1, 2, 3, BScH, MSc;  Roumen Milev 1, 2, 3, 4, MD, PhD, FRCPC, FRCPsych

1 Centre for Neuroscience Studies, Queen's University , Kingston, ON, CA

2 Providence Care Hospital , Kingston, ON, CA

3 Department of Psychiatry, Queen's University , Kingston, ON, CA

4 Department of Psychology, Queen's University , Kingston, ON, CA

Corresponding Author: